Summary Trends in eye cancer mortality are presented for the USA and England and Wales during the period 1955-89. Mortality rates have fallen by 58% in the USA during this period. The fall in mortality is paralleled by an equal fall in incidence rates in the USA. In England and Wales, mortality rates and incidence rates have remained relatively constant during the last three decades. The explanation for these differences between the USA and England and Wales is unknown.
Eye cancers are rare tumours, accounting for less than 0.1 % of all cancer deaths in the USA and England and Wales. In childhood, most eye cancers are retinoblastomas and rhabdomyosarcomas, whereas in adults about 90% of eye cancers are melanomas (Hakulinen et al., 1978) , mainly of the uveal tract (Scotto et al., 1976) .
Little is known about the epidemiology of adult cancers or ocular melanomas. Several epidemiological studies have studied the role of solar ultraviolet radiation and have provided only limited support for it being an aetiological factor for ocular melanoma (Tucker et al., 1985; Seddon et al., 1990a; Holly et al., 1990; Gallagher et al., 1985) . Occupational hazards associated with ocular melanoma include welding exposure, asbestos exposure and working as a chemist or chemical technician (Tucker et al., 1985; Holly et al., 1996) . There has been one report of a small cluster of cases seen at one chemical works, but no causative agent was identified (Albert et al., 1980) . Polychlorinated biphenyls have been suggested as a risk factor for cutaneous melanoma but not for uveal melanoma (Davidorf and Knupp, 1979) . This study examines eye cancer incidence and mortality among adults in the USA and England and Wales.
Materials and methods
Eye cancers are coded under the ICD system ICD-6:192, ICD-7: 192 (World Health Organization, 1957) , ICD-8: 190 (World Health Organization, 1967) and ICD-9:190 (World Health Organization, 1978) and include cancers of the eyeball, orbit, lachrymal gland, conjunctiva, cornea, retina and lachrymal sac but excludes cancers of the eyelid and orbital bone, and all cancers in which the eye is a secondary site.
This analysis concentrates on eye cancers in persons aged 40 or older. Ninety per cent of cases of cancer of the eye in adults are ocular melanomas; the large majority of these are of the uveal tract, and it has become standard practice to take eye cancers in adults as a surrogate measure for uveal melanoma (Hakulinen et al., 1978; Strickland and Lee, 1981; Swerdlow, 1983 Incidence rates Figure 2 included in but are excluded from (Callendar, 1931; Wilder and Callendar, 1939 
Cancer of the eye AJE Foss and PJ Dolin e 1689 techniques have not improved survival (Augsburger 1990; Seddon et al., 1990b; Foulds et al., 1987 Foulds et al., , 1991 . In addition, no satisfactory treatment for metastatic uveal melanoma existed during the study period (Albert et al., 1992) .
In England and Wales, survival for adult eye cancers has remained steady over the last two decades. During 1971-74, 5 year survival was 59%, and in 1980-84 the 5 year survival was 61% (unpublished OPCS data). However, there have been reports from Denmark and Sweden of slight improvements in survival, but it is extremely unlikely that this would be of sufficient magnitude to result in a 50% fall in mortality. Discussion with ophthalmic oncologists in the USA does not suggest any dramatic move towards earlier detection or a more informed public in the USA compared with England and Wales.
Changes in incidence
The alternative explanation is that mortality rates in the USA have fallen because the underlying incidence rates have also fallen, whereas in England and Wales underyling incidence rates have remained relatively constant. Figure 2a shows the age-standardise incidence rates in the USA for 1973-1989 and Figure 2b those for England and Wales for 1971-1988. In the USA, the male age-standardised incidence rates fell by 25% over an 18 year period from 1973 to 1989 (an annual average fall of 1.4%), which parallels the observed 55% fall in male mortality rates over 35 years (an annual average fall of 1.6%). The USA female incidence rate also shows a downward trend, falling by 28% over the same period. In England and Wales, incidence rates have fluctuated with little evidence of a downward trend in either age-standardised rates or age-specific rates for either men or women. Although there has been an apparent reduction in female mortality rates since 1970-74 in England and Wales there has been no corresponding fall in female incidence rates.
This observed fall in mortality and incidence rates in the USA invites hypotheses about possible changes in exposure risk factors. Unfortunately, at this time, little is known about the aetiology of eye cancer in adults.
